Status:
COMPLETED
Silicone Gel Versus Onion Extract Gel as Prevention for Postsurgical Scars
Lead Sponsor:
CHA University
Conditions:
Hypertrophic or Keloid Scars
Eligibility:
FEMALE
18-75 years
Phase:
PHASE3
Brief Summary
Hypertrophic or keloid scars develop for about 39% to 68% of patients after surgery. The subjective opinion of the patient regarding the scar will often constitute the standard for judging the success...
Eligibility Criteria
Inclusion
- over 18 years of age,
- Asian,
- at least 3 cm sized surgical wound in total length,
- nonpregnant at the time of presentation (i.e., negative for urine pregnancy test or last menstrual period within the last 4 weeks),
- able to read and write informed consent and questionnaire.
Exclusion
- women who received nearly scar-free surgery such as laparoendoscopic single-site (LESS) surgery or natural orifice transluminal surgery (NOTES);
- women who developed surgical complications such as wound infection
- women who had a history of hypertrophic or keloid scarring in abdomen
- women who were taking chemotherapeutic agents or other medications that would affect wound healing, such as steroids
- women who had comorbidities such as diabetes, contractive skin disorders (e.g., scleroderma), or active dermatologic conditions
- women who had allergy to silicone or onion.
Key Trial Info
Start Date :
April 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2014
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT01861119
Start Date
April 1 2013
End Date
May 1 2014
Last Update
August 28 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHA Gangnam Medical Center
Seoul, South Korea, 135-081